Deborah L. Burkhart
- Oncology top 5%
- Cancer-related Molecular Pathways 7
- Cancer Research top 10%
- Molecular Biology top 10%
- Ubiquitin and proteasome pathways 3
- Epigenetics and DNA Methylation 2
- RNA modifications and cancer 2
- Metabolomics and Mass Spectrometry Studies 1
- Immunology top 10%
- Ophthalmology top 5%
- Ocular Oncology and Treatments 4
-
- Prostate Cancer Treatment and Research 3
-
- Virus-based gene therapy research 1
- Co-authors
- Julien SageGérard I. EvanCatherine H. WilsonTrevor D. LittlewoodLuca PellegrinetRoderik M. KortleverLamorna Brown SwigartNicole M. Sodir
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Deborah L. Burkhart
15 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Oncology 816
- Cancer Research 308
- Molecular Biology 927
- Immunology 235
- Ophthalmology 97
Countries citing papers authored by Deborah L. Burkhart
This map shows the geographic impact of Deborah L. Burkhart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah L. Burkhart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah L. Burkhart more than expected).
Fields of papers citing papers by Deborah L. Burkhart
This network shows the impact of papers produced by Deborah L. Burkhart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah L. Burkhart. The network helps show where Deborah L. Burkhart may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Deborah L. Burkhart, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2024 | 4 | |
| 3 | 2022 | 53 | |
| 4 | 2020 | 4 | |
| 5 | 2020 | 24 | |
| 6 | 2020 | 44 | |
| 7 | 2019 | 16 | |
| 8 | 2017 | 353 | |
| 9 | 2017 | 6 | |
| 10 | 2016 | 61 | |
| 11 | 2010 | 161 | |
| 12 | 2010 | 28 | |
| 13 | 2010 | 37 | |
| 14 | 2008 | 8 | |
| 15 | Cellular mechanisms of tumour suppression by the retinoblastoma genebreakdown → | 2008 | 686 |
About Deborah L. Burkhart
Deborah L. Burkhart is a scholar working on Ophthalmology, Oncology and Biochemistry, having authored 15 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (7 papers), Ocular Oncology and Treatments (4 papers), Ubiquitin and proteasome pathways (3 papers), Prostate Cancer Treatment and Research (3 papers), Epigenetics and DNA Methylation (2 papers), RNA modifications and cancer (2 papers), Metabolomics and Mass Spectrometry Studies (1 paper) and Virus-based gene therapy research (1 paper). The work is most often cited by research in Oncology (816 citations), Cancer Research (308 citations) and Molecular Biology (927 citations). Deborah L. Burkhart has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Julien Sage, Gérard I. Evan, Catherine H. Wilson, Trevor D. Littlewood, Luca Pellegrinet, Roderik M. Kortlever, Lamorna Brown Swigart, Nicole M. Sodir, E. Alejandro Sweet‐Cordero and Anthony N. Karnezis. Their work appears in journals such as Cell, Nature Communications and Nature reviews. Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.